Patents by Inventor Percy Minden

Percy Minden has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Synthetic polypeptides and receptor molecules derived therefrom and methods of use
    Patent number: 4889800
    Abstract: Antigens, immunogens, inocula, antibodies, receptors, diagnostic methods and systems relating to tuberculosis mycobacteria are disclosed. Each of the compounds, compositions, methods or systems contains about 40 residues, or an antibody containing site that immunoreacts with such a polypeptide. The polypeptide includes the thirteen or fourteen amino acid reside sequence (AlaLysValAsnIleLysProLeuGluAspLysIleCys) or (CysAlaLysValAsnIleLysproLeuGluAspLysIleCys). When linked to a carrier and introduced in an effective amount into a mammalian host, the polypeptide is capable of inducing production of antibodies that immunoreact with an antigen to a tuberculous mycobacterium.
    Type: Grant
    Filed: August 21, 1987
    Date of Patent: December 26, 1989
    Assignee: Scripps Clinic and Research Foundation
    Inventors: Thomas M. Shinnick, Percy Minden, Richard A. Houghten
  • Synthetic polypeptides for detecting mycobacterial infections
    Patent number: 4689397
    Abstract: Antigens, immunogens, inocula, antibodies, diagnostic methods and systems relating to tuberculous mycobacteria are disclosed. Each of the compounds, compositions, methods or systems contains a synthetic polypeptide having about 13 or 14 to about 40 residues, or an antibody containing site that immunoreacts with such a polypeptide. The polypeptide includes the thirteen or fourteen amino acid reside sequence (AlaLysValAsnIleLysProLeuGluAspLysIleCys) or (CysAlaLysValAsnIleLysProLeuGluAspLysIleCys). When linked to a carrier and introduced in an effective amount into a mammalian host, the polypeptide is capable of inducing production of antibodies that immunoreact with an antigen to a tuberculous mycobacterium.
    Type: Grant
    Filed: August 12, 1985
    Date of Patent: August 25, 1987
    Assignee: Scripps Clinic and Research Foundation
    Inventors: Thomas M. Shinnick, Percy Minden, Richard A. Houghten